Having shown that TOPK inhibition exhibits preferential anti-leukemia activity in AML with FLT3-ITD, we speculated that TOPK expression or kinase activity is upregulated in FLT3-ITD cells compared to FLT3-wt cells. The gene discussed is PBK; the disease is acute myeloid leukemia.